An open pilot study of the effect and tolerability of add-on multivitamin therapy in patients with intractable focal epilepsy

研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)

摘要

Observational studies have investigated the potential modulatory effect of neuronal excitability by vitamins in epilepsy. We aimed to investigate whether the addition of multivitamin therapy (B6/B9, D, E and Q) to regular antiepileptic drug therapy could ameliorate seizures in patients with refractory focal epilepsy. We conducted a prospective cohort open study to investigate the effect and tolerability of add-on multivitamin therapy (daily dose: B6 100 mg, B9 5 mg, D 1000 IU, E 400 IU and coenzyme Q10 100 mg) in patients with intractable focal epilepsy. All patients had effect and safety assessments at baseline and after one, three and six months of the supplementation. Thirty patients (11 men and 19 women) with a mean age of 42.37 ± 9.40 years were recruited and four patients discontinued. The seizure frequency significantly decreased after the six-month supplementation (9.04 ± 18.16/month and 2.06 ± 3.89/month, p = 0.045). At the final visit, 62.5% of the patients showed a ≥50% reduction in seizure frequency, and 12.5% were seizure-free. As to safety and tolerability, most patients did not experience significant adverse events, although three patients reported seizure worsening. In conclusion, this pilot study demonstrated the therapeutic potential and essentially good tolerability of add-on multivitamin therapy in patients with refractory focal epilepsy.

原文English
文章編號2359
頁(從 - 到)1-13
頁數13
期刊Nutrients
12
發行號8
DOIs
出版狀態Published - 2020 八月

All Science Journal Classification (ASJC) codes

  • Food Science
  • Nutrition and Dietetics

指紋 深入研究「An open pilot study of the effect and tolerability of add-on multivitamin therapy in patients with intractable focal epilepsy」主題。共同形成了獨特的指紋。

引用此